Article metrics

Further improvement in glycemic control after switching from exenatide two times per day to exenatide once-weekly autoinjected suspension in patients with type 2 diabetes: 52-week results from the DURATION-NEO-1 study

 

Online download statistics by month:

Online download statistics by month: October 2020 to January 2024

AbstractFullPdf
Oct 202016916893
Nov 2020555331
Dec 2020353513
Jan 2021333210
Feb 202126259
Mar 2021242410
Apr 2021322815
May 2021191811
Jun 2021353416
Jul 2021363421
Aug 2021393939
Sep 2021222116
Oct 2021242431
Nov 2021212016
Dec 2021212216
Jan 2022424716
Feb 2022353217
Mar 2022323314
Apr 2022505112
May 2022313115
Jun 202215156
Jul 202237345
Aug 2022262614
Sep 2022252517
Oct 2022333429
Nov 202217167
Dec 2022201911
Jan 2023222210
Feb 2023525313
Mar 202325256
Apr 2023212211
May 2023151510
Jul 202327298
Aug 202318186
Sep 2023232311
Oct 202334349
Nov 202326215
Dec 2023363617
Jan 2024222013
Total12751258629